Galectin Therapeutics Inc.GALTNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-41.77M
↓ 89% below average
Average (9y)
$-22.10M
Historical baseline
Range
High:$-10.18M
Low:$-41.77M
CAGR
+10.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-41.77M | -26.7% |
| 2023 | $-32.97M | -6.1% |
| 2022 | $-31.06M | -27.8% |
| 2021 | $-24.31M | -18.0% |
| 2020 | $-20.60M | -89.9% |
| 2019 | $-10.85M | -6.6% |
| 2018 | $-10.18M | +35.9% |
| 2017 | $-15.89M | +3.2% |
| 2016 | $-16.41M | +3.4% |
| 2015 | $-16.98M | - |